Skip to content

BHI Therapeutic Sciences Jamaica

Dedicated to investigational stem cell research

  • About Us
    • IRB Approved Protocols
    • Privacy Policy
  • Leadership
    • Scientific Advisory Board
  • About Stem Cells
  • Research Applications
    • IRB Approved Protocols
    • Cell Quality and Donor Screening
    • Research Study Process
    • Patient Forms
  • Why Jamaica?
  • Testimonials
  • Photo Gallery
  • News
  • Events
  • Donations
  • Invest
  • Stem Cell Q&A Group
  • Contact Us
Posted on November 12, 2020November 12, 2020 by bluehorizon

Stem Cell Guru- Episode 4

Categoriesnews

Post navigation

Previous PostPrevious Paper from BHI Therapeutic Sciences and Blue Horizon International, Slovakia Published in the Journal of Clinical Medicine Research
Next PostNext Brian Mehling, M.D. presented at the Neuroscience 20 | SBMT virtual summit on November 21, 2020

Search

The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our cellular and exosome products are investigational, are not FDA-approved, and are not intended to diagnose, treat, cure, or prevent any disease. The information provided here is for educational purposes only and is not medical advice.

  • Email
Proudly powered by WordPress